Our News
Brendan Martin on the Pharmaphorum Podcast
September 10, 2020
Alnylam Pharmaceuticals
Alnylam’s Brendan Martin, Head of Europe, Middle East, Africa, and Canada and General Manager for the UK & Ireland, recently spoke with Dominic Tyer on the Pharmaphorum podcast about a broad range of topics including the state of the UK biotechnology industry, lessons learned during the COVID-19 pandemic, and what it means to be leader in the life sciences in 2020. Brendan also explained how RNAi (RNA interference) therapeutics silence genes and why we believe RNAi has the potential to yield new treatment options to combat SARS-CoV-2, the virus that causes COVID-19, and other coronaviruses.
Tags
Perspectives, Podcasts, RNAi, Brendan Martin, Executive Team, COVID-19
